Loading...
•
Jun 30, 2022
DexCom Q2 2022 Earnings Report
Dexcom's revenue grew, driven by volume growth and new customer additions, with international growth outpacing US growth. The company advanced its CGM portfolio strategy with launches in the UK and Spain and received CE Mark for an updated sensor algorithm.
Key Takeaways
Dexcom reported a 17% increase in revenue to $696.2 million for Q2 2022, driven by volume growth and new customer additions. U.S. revenue grew by 11%, while international revenue increased by 39%. GAAP operating income was $77.0 million, and GAAP net income was $50.9 million, or $0.12 per diluted share.
Revenue grew 17% versus the same quarter of the prior year to $696.2 million.
U.S. revenue growth of 11% and international revenue growth of 39%.
GAAP operating income of $77.0 million or 11.1% of revenue.
Advanced CGM portfolio strategy, including the launches of Dexcom ONE in the UK and Spain.
DexCom
DexCom
DexCom Revenue by Segment
DexCom Revenue by Geographic Location
Revenue by Segment
Sensor and other Revenue
CapyFin.comHardware Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The company is updating fiscal year 2022 revenue guidance, and reiterating guidance for Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin at the following levels:
Positive Outlook
- Revenue of approximately $2.86 - 2.91 billion (17-19% growth)
- Non-GAAP Gross Profit Margin of approximately 65%
- Non-GAAP Operating Margin of approximately 16%
- Adjusted EBITDA Margin of approximately 25%
Revenue & Expenses
Visualization of income flow from segment revenue to net income